Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
MS Focus At Sea
MS Focus At Sea offers educational programs, opportunities to meet old and new friends, and adventures for every...
/Events/MSF-Events/MSFocus-Cruise-For-A-Cause
Healthcare Assistance ...
The MS Focus Healthcare Assistance Grant assists uninsured individuals with the cost of visiting...
/Get-Help/MSF-Programs-Grants/Healthcare-Assistance-Grant
Shop
Privacy
Terms of Use
Site Map
Study: Altering reelin levels a possible new treatment for MS
August 14, 2020
A new study suggests decreasing the amount of a protein made in the liver significantly protected against development of the disease’s characteristic symptoms and promoted recovery in an animal model of multiple sclerosis. The findings could lead to a new treatment strategy for this neurological disease and other conditions marked by chronic inflammation.
In 1997, researchers discovered a protein secreted in the brain called reelin. Subsequent work showed reelin appears to help the brain organize itself during development and assist in forming connections between brain cells during adulthood. However, as researchers learned more about reelin, they discovered that large amounts of it are produced in the liver and cells lining blood vessels have receptors for this protein.
Researchers at the UT Southwestern Medical Center investigated this protein’s role in MS. They started by examining blood concentrations of reelin in patients with relapsing-remitting MS. They found that while reelin concentrations were about the same in patients in remission as those without the disease, concentrations were elevated in patients during relapse. These findings suggest that circulating reelin levels might correlate with MS severity and stages, and lowering reelin levels might be a novel way to treat MS.
Investigating further, researchers worked with mice affected by experimental autoimmune encephalomyelitis, a condition that mimics human MS. When these animals were genetically modified so the researchers could control reelin production, they found that eliminating this protein substantially mitigated the disease’s typical paralysis or even eliminated it altogether, in contrast to mice with normal reelin levels. These effects appeared to stem from the lack of monocyte adhesion on the altered animals’ blood vessel walls, which prevented entry into the central nervous system.
The researchers had further success preventing paralysis when unaltered animals with EAE received antibodies that deactivated reelin. This strategy was even effective in animals that already displayed symptoms of the disease – a situation that more closely mimics human patients diagnosed with MS – reducing paralysis severity and promoting healing.
Results of mouse model studies sometimes do not translate to humans and may be years away from being a marketable treatment. However, the researchers suggest that reducing immune cells’ ability to accumulate and cause inflammation by altering reelin levels could represent a new strategy for treating patients with MS.
The findings were published in the journal
Science Translational Medicine
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more